Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticles
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
RIF-loaded solid lipid nanoparticles are suitable for alveolar macrophage targeted delivery due to specific internalization of nanosized SLNs into alveolar macrophages.
“Further RIF-loaded SLNs have been found to be suitable for AM targeted delivery due to the specific internalization of nanosized SLNs into AM.218”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [218]
Pulmonary administration of rifampicin-loaded solid lipid nanoparticles in rats enabled delivery to alveolar macrophages.
“pulmonary administration of rifampicin-loaded solid lipid nanoparticles in rats enabled delivery to alveolar macrophages 131 .”
From Nanotechnology approaches for global infectious diseases (2021) · cites this paper as [131]
Cites
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,816 · see citing works
Bethke, T. D. (2012) · Der Pneumologe · doi:10.1007/s10405-012-0601-3 · Cited by 3,286 · see citing works
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854 · see citing works
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607 · see citing works
McKinney, J. D., zu Bentrup, K. H., Muñoz‐Elías, E. J., Miczák, A., Chen, B., Chan, W.-T., Swenson, D. L., Sacchettini, J. C., Jacobs, W. R., & Russell, D. G. (2000) · Nature · doi:10.1038/35021074 · Cited by 1,361 · see citing works
Armstrong, J. A., & Hart, P. D. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.134.3.713 · Cited by 991 · see citing works
A Coat Protein on Phagosomes Involved in the Intracellular Survival of Mycobacteria
Ferrari, G., Langen, H., Naito, M., & Pieters, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80754-0 · Cited by 579 · see citing works
CELL BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS PHAGOSOME
Vergne, I., Chua, J., Singh, S., & Deretic, V. P. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.114015 · Cited by 440 · see citing works
Pandey, R., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2004.11.003 · Cited by 318 · see citing works
Oral solid lipid nanoparticle-based antitubercular chemotherapy
Pandey, R., Sharma, S., & Khuller, G. K. (2005) · Tuberculosis · doi:10.1016/j.tube.2005.08.009 · Cited by 271 · see citing works
Allen, L. H., & Aderem, A. A. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80102-6 · Cited by 267 · see citing works
Therapeutic potential of nanoparticulate systems for macrophage targeting
Chellat, F., Merhi, Y., Moreau, A., & Yahia, L. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.05.044 · Cited by 237 · see citing works
Delivery systems to increase the selectivity of antibiotics in phagocytic cells
Briones, E., Colino, C. I., & Lanao, J. M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.027 · Cited by 226 · see citing works
The Trojan horse: survival tactics of pathogenic mycobacteria in macrophages
Nguyen, L., & Pieters, J. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.03.009 · Cited by 204 · see citing works
Non-invasive pulmonary aerosol delivery in mice by the endotracheal route
Bivas‐Benita, M., Zwier, R., Junginger, H. E., & Borchard, G. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.04.009 · Cited by 201 · see citing works
Chono, S., Tanino, T., Seki, T., & Morimoto, K. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.1.0010 · Cited by 190 · see citing works
Hirota, K., Hasegawa, T., Hinata, H., Ito, F., Inagawa, H., Kochi, C., Soma, G., Makino, K., & Terada, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.013 · Cited by 178 · see citing works
Relevance of the colloidal stability of chitosan/PLGA nanoparticles on their cytotoxicity profile
Nafee, N. A., Schneider, M., Schaefer, U. F., & Lehr, C. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.049 · Cited by 176 · see citing works
Alkaline Phosphatase: A Marker of Alveolar Type II Cell Differentiation
Edelson, J. D., Shannon, J. M., & Mason, R. J. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/138.5.1268 · Cited by 173 · see citing works
Chono, S., Tanino, T., Seki, T., & Morimoto, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.011 · Cited by 164 · see citing works
Wijagkanalan, W., Kawakami, S., Takenaga, M., Igarashi, R., Yamashita, F., & Hashida, M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.011 · Cited by 159 · see citing works
Chono, S., Tanino, T., Seki, T., & Morimoto, K. (2006) · Journal of drug targeting · doi:10.1080/10611860600834375 · Cited by 155 · see citing works
Drug Treatment for Tuberculosis during Pregnancy
Bothamley, G. H. (2001) · Drug Safety · doi:10.2165/00002018-200124070-00006 · Cited by 152 · see citing works
Hirota, K., Hasegawa, T., Nakajima, T., Inagawa, H., Kohchi, C., Soma, G., Makino, K., & Terada, H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.020 · Cited by 129 · see citing works
Isolation of highly pure alveolar epithelial type I and type II cells from rat lungs
Chen, J., Chen, Z., Narasaraju, T. A., Jin, N., & Liu, L. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700095 · Cited by 114 · see citing works
Li, Y., Sun, X., Gong, T., Liu, J., Zuo, J., & Zhang, Z. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0201-z · Cited by 103 · see citing works
Self-citationMolecular mechanisms regulating persistent Mycobacterium tuberculosis infection
Zahrt, T. C. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(02)00083-7 · Cited by 87 · see citing works
Panchagnula, R., Sood, A., Sharda, N., Kaur, K., & Kaul, C. L. (1999) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(98)00112-5 · Cited by 73 · see citing works
Post, M., & Smith, B. T. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/137.3.525 · Cited by 68 · see citing works
Innate immune responses to M. tuberculosis infection
Natarajan, K., Kundu, M., Sharma, P., & Basu, J. (2011) · Tuberculosis · doi:10.1016/j.tube.2011.04.003 · Cited by 56 · see citing works
The behavior of PLGA microspheres containing rifampicin in alveolar macrophages
Onoshita, T., Shimizu, Y., Yamaya, N., Miyazaki, M., Yokoyama, M., Fujiwara, N., Nakajima, T., Makino, K., Terada, H., & Haga, M. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.10.036 · Cited by 54 · see citing works
Albrecht, C., Scherbart, A. M., van Berlo, D., Braunbarth, C. M., Schins, R. P. F., & Scheel, J. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.01.005 · Cited by 48 · see citing works
Pallanza, R., Arioli, V., Fürész, S., & Bolzoni, G. (1967) · PubMed · Cited by 47 · see citing works
Cellular targeting and trafficking of drug delivery systems for the prevention and treatment of MTb
Lawlor, C., Kelly, C., O’Leary, S. M., O’Sullivan, M. P., Gallagher, P., Keane, J., & Cryan, S. (2011) · Tuberculosis · doi:10.1016/j.tube.2010.12.001 · Cited by 32 · see citing works
Krist, L. F. G., Kerremans, M., Koenen, H. J. P. M., Blijleven, N., Eestermans, I. L., Calame, W., Meyer, S., & Beelen, R. H. J. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(95)00096-s · Cited by 17 · see citing works
Drug Treatment of Tuberculosis: I. Standard Chemotherapy
Crofton, J. (1960) · BMJ · doi:10.1136/bmj.2.5195.370 · Cited by 15 · see citing works
Preparation of Rifampicin-solid lipid nanoparticles and evaluation of their cell specificity
Zhang, Z. (2011) · Huaxi yaoxue zazhi · Cited by 1 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
Singh, A. P., Biswas, A., Shukla, A., & Maiti, P. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0068-3 · Cited by 645 · see citing works
Nanotechnology approaches for global infectious diseases
Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520 · see citing works
Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
Paranjpe, M., & Müller-Goymann, C. C. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045852 · Cited by 454 · see citing works
Doktorovová, S., Souto, E. B., & Silva, A. M. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.02.005 · Cited by 419 · see citing works
Physicochemical properties affecting the fate of nanoparticles in pulmonary drug delivery
Liu, Q., Guan, J., Lu, Q., Zhang, X., & Mao, S. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.09.023 · Cited by 230 · see citing works
Solid lipid nanocarriers in drug delivery: characterization and design
Mu, H., & Holm, R. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1504018 · Cited by 145 · see citing works
The formulation of nanomedicines for treating tuberculosis
Costa, A., Pinheiro, M., Magalhães, J., Ribeiro, R., Seabra, V., Reis, S., & Sarmento, B. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.012 · Cited by 123 · see citing works
Bhattacharjee, R., Kumar, L., Mukerjee, N., Anand, U., Dhasmana, A., Preetam, S., Bhaumik, S., Sihi, S., Pal, S., Khare, T. R., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113658 · Cited by 115 · see citing works
RetractedCai, W., Weng, X., & Chen, Z. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.01.108 · Cited by 108 · see citing works
Shah, K. U., Chan, L. W., & Wong, T. W. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1384298 · Cited by 90 · see citing works
Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis
Maretti, E., Rossi, T., Bondi, M., Croce, M. A., Hanuskovà, M., Leo, E., Sacchetti, F., & Iannuccelli, V. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.12.034 · Cited by 84 · see citing works
Song, X. C., Lin, Q., Guo, L. H., Fu, Y. S., Han, J., Ke, H., Sun, X., Gong, T., & Zhang, Z. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1572-3 · Cited by 82 · see citing works
Self-citationKaramanis, P., Otero, N., & Pouchan, C. (2014) · Journal of the American Chemical Society · doi:10.1021/ja502631w · Cited by 81 · see citing works
Makled, S., Nafee, N. A., & Boraie, N. A. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.12.026 · Cited by 82 · see citing works
Visible Light Catalysis-Assisted Assembly of Nih-QD Hollow Nanospheres in Situ via Hydrogen Bubbles
Li, Z., Fan, X., Li, X., Li, J., Ye, C., Wang, J.-J., Yu, S., Li, C., Gao, Y., Meng, Q., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5047236 · Cited by 78 · see citing works
Preparation and characterization of isoniazid-loaded crude soybean lecithin liposomes
Nkanga, C. I., Krause, R. W. M., Siwe‐Noundou, X., & Walker, R. B. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.04.074 · Cited by 74 · see citing works
Graphene metal nanocomposites — Recent progress in electrochemical biosensing applications
Khalil, I., Rahmati, S., Julkapli, N. M., & Yehye, W. A. (2017) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2017.11.001 · Cited by 69 · see citing works
How can nanoparticles contribute to antituberculosis therapy?
Costa-Gouveia, J., Aínsa, J. A., Brodin, P. M., & Lucía, A. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.01.011 · Cited by 68 · see citing works
Heras, I. L., Theodorou, I. G., Leo, B. F., Ryan, M. P., & Porter, A. E. (2015) · Environmental Science Nano · doi:10.1039/c5en00051c · Cited by 67 · see citing works
Pinheiro, M., Couto, A., Chaves, L. L., Ferreira, D., Sarmento, B. F. C. C., & Reis, S. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s104908 · Cited by 65 · see citing works
Nafee, N. A., Makled, S., & Boraie, N. A. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.10.003 · Cited by 62 · see citing works
Mehanna, M. M., Mohyeldin, S. M., & Elgindy, N. A. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s211182 · Cited by 53 · see citing works
Zhao, X., Liu, S., Wang, P., Tang, Z., Niu, H., Cai, Y., Wu, F., Wang, H., Meng, W., & Giesy, J. P. (2015) · Journal of Chromatography A · doi:10.1016/j.chroma.2015.07.105 · Cited by 51 · see citing works
Comparative Pulmonary Toxicity of Two Ceria Nanoparticles with the Same Primary Size
Peng, L., He, X. B., Zhang, P., Zhang, J., Li, Y., Zhang, J., Ma, Y., Ding, Y., Wu, Z., Chai, Z., et al. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15046072 · Cited by 51 · see citing works
Self-citationRole of Novel Drug Delivery Vehicles in Nanobiomedicine
Tyagi, R. K. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.77468 · Cited by 50 · see citing works
Ren, C., Ding, X., Li, W., Wu, H., & Yang, H. Y. (2017) · Journal of Chemical & Engineering Data · doi:10.1021/acs.jced.7b00198 · Cited by 47 · see citing works
Husnain, S. M., Um, W., Chang, Y., & Chang, Y. (2016) · Chemical Engineering Journal · doi:10.1016/j.cej.2016.09.116 · Cited by 44 · see citing works
Is Nanotechnology Helping in the Fight Against COVID-19?
Cardoso, V. M. D. O., Moreira, B. J., Comparetti, E. J., Sampaio, I., Ferreira, L. M. B., Lins, P. M. P., & Zucolotto, V. (2020) · Frontiers in Nanotechnology · doi:10.3389/fnano.2020.588915 · Cited by 41 · see citing works
Nanosized Drug Delivery Systems to Fight Tuberculosis
Bourguignon, T., Godinez-Leon, J. A., & Gref, R. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020393 · Cited by 40 · see citing works
Asdaq, S. M. B., Ikbal, A. M. A., Sahu, R. K., Bhattacharjee, B., Paul, T., Deka, B., Fattepur, S., Widyowati, R., Vijaya, J., Mohaini, M. A., et al. (2021) · Nanomaterials · doi:10.3390/nano11071841 · Cited by 41 · see citing works
Sarkar, K., Kumar, M., Jha, A., Bharti, K., Das, M., & Mishra, B. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102850 · Cited by 36 · see citing works
da Silva, P. B., de Souza, P. C., Calixto, G. M. F., Lopes, É. D. O., Frem, R. C. G., Netto, A. V. G., MAURO, A. E., Pavan, F. R., & Chorilli, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050745 · Cited by 35 · see citing works
Ge, Z., Ma, R., Xu, G., Chen, Z., Zhang, D., Wang, Q., Hei, L., & Wei, M. (2018) · Medical Science Monitor · doi:10.12659/msm.905581 · Cited by 35 · see citing works
Nanoparticle-mediated macrophage targeting—a new inhalation therapy tackling tuberculosis
Makled, S., Boraie, N. A., & Nafee, N. A. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00815-3 · Cited by 34 · see citing works
Goli, P. P., Torbati, M. B., Parivar, K., Akbarzadeh, A., & Yousefi, M. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102756 · Cited by 32 · see citing works
Chen, M., Shou, Z., Jin, X., & Chen, Y. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2089294 · Cited by 32 · see citing works
Nanomedicines towards targeting intracellular Mtb for the treatment of tuberculosis
Donnellan, S., & Giardiello, M. (2019) · Journal of Interdisciplinary Nanomedicine · doi:10.1002/jin2.61 · Cited by 31 · see citing works
Nkanga, C. I., Walker, R. B., & Krause, R. W. M. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.03.016 · Cited by 29 · see citing works
Poh, W., Rahman, N. B. A., Ostrovski, Y., Sznitman, J., Pethe, K., & Loo, S. C. J. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1676841 · Cited by 29 · see citing works
Potential of nanotechnology as a delivery platform against tuberculosis: Current research review
Choudhary, S., & Devi, V. K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.035 · Cited by 28 · see citing works
In vitro controlled release of Rifampicin through liquid-crystalline folate nanoparticles
Parmar, R., Misra, R. D., & Mohanty, S. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.03.051 · Cited by 28 · see citing works
Prabhavathi, G., Arjun, M. S., & Yamuna, R. (2017) · Journal of Chemical Sciences · doi:10.1007/s12039-017-1295-1 · Cited by 28 · see citing works
Nishimura, S., Takami, T., & Murakami, Y. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.08.004 · Cited by 28 · see citing works
Nkanga, C. I., & Krause, R. W. M. (2018) · Applied Nanoscience · doi:10.1007/s13204-018-0776-y · Cited by 27 · see citing works
Bentarhlia, N., Elansary, M., Belaiche, M., Mouhib, Y., Lemine, O. M., Zaher, H., Oubihi, A., Kartah, B. E., & Monfalouti, H. E. (2023) · Ceramics International · doi:10.1016/j.ceramint.2023.10.017 · Cited by 25 · see citing works
Facile synthesis of novel flowerlike magnetic mesoporous carbon for efficient chlorophenols removal
Liu, S., Li, S., Niu, H., Zeng, T., Cai, Y., Shi, C., Zhou, B., Wu, F., & Zhao, X. (2014) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2014.08.046 · Cited by 25 · see citing works
Joshi, M., & Prabhakar, B. R. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.102197 · Cited by 24 · see citing works
Khoza, L. J., Kumar, P., Dube, A., Demana, P. H., & Choonara, Y. E. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121893 · Cited by 24 · see citing works
Sahoo, P., Dey, J., Mahapatra, S. R., Ghosh, A., Jaiswal, A., Padhi, S., Prabhuswamimath, S. C., Misra, N., & Suar, M. (2022) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2022.0072 · Cited by 24 · see citing works
Graphene oxide functionalized by poly(ionic liquid)s for carbon dioxide capture
Huang, L., Jin, Y., Sun, L. J., Chen, F., Fan, P., Zhong, M., & Yang, J. (2016) · Journal of Applied Polymer Science · doi:10.1002/app.44592 · Cited by 23 · see citing works
Chokshi, N. V., Rawal, S. U., Solanki, D., Gajjar, S., Bora, V. R., Patel, B. M., & Patel, M. M. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.02.018 · Cited by 23 · see citing works
Mukhtar, M., Szakonyi, Z., Farkas, Á., Burián, K., Kókai, D., & Ambrus, R. (2021) · European Polymer Journal · doi:10.1016/j.eurpolymj.2021.110775 · Cited by 22 · see citing works
Shrivastava, P., Gautam, L., Sharma, R. K., Dube, D., Vyas, S., & Vyas, S. P. (2020) · Journal of Microencapsulation · doi:10.1080/02652048.2020.1857861 · Cited by 22 · see citing works
Suman, S. K., Chandrasekaran, N., & Doss, C. G. P. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00088-23 · Cited by 20 · see citing works
The Role of Langmuir Monolayers To Understand Biological Events
Caseli, L., Nobre, T. M., Ramos, A. P., Monteiro, D. S., & Zaniquelli, M. E. D. (2015) · ACS symposium series · doi:10.1021/bk-2015-1215.ch004 · Cited by 20 · see citing works
Cure of tuberculosis using nanotechnology: An overview
Kerry, R. G., Gouda, S., Sil, B., Das, G., Shin, H., Ghodake, G. S., & Patra, J. K. (2018) · The Journal of Microbiology · doi:10.1007/s12275-018-7414-y · Cited by 20 · see citing works
Photobleaching-resistant ternary quantum dots embedded in a polymer-coated silica matrix
Guguła, K., Szydło, A., Stegemann, L., Strassert, C. A., & Bredol, M. (2016) · Journal of Materials Chemistry C · doi:10.1039/c6tc00943c · Cited by 20 · see citing works
Automated determination of Rifamycins making use of MPA–CdTe quantum dots
Jiménez-López, J., Molina‐García, L., Rodrigues, S. S. M., Santos, J. L. M., Ortega-Barrales, P., & Ruiz-Medina, A. (2016) · Journal of Luminescence · doi:10.1016/j.jlumin.2016.02.036 · Cited by 19 · see citing works
Lipid nanoparticles with improved biopharmaceutical attributes for tuberculosis treatment
Gordillo-Galeano, A., Ospina-Giraldo, L. F., & Mora‐Huertas, C. E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120321 · Cited by 19 · see citing works
Devi, R. A., Prabhavathi, G., Yamuna, R., Ramakrishnan, S., & Kothurkar, N. K. (2014) · Journal of Chemical Sciences · doi:10.1007/s12039-013-0536-1 · Cited by 17 · see citing works
Use of nanotechnology in combating coronavirus
Gharpure, S., & Ankamwar, B. G. (2021) · 3 Biotech · doi:10.1007/s13205-021-02905-6 · Cited by 17 · see citing works
Review of inhalable nanoparticles for the pulmonary delivery of anti-tuberculosis drugs
Ramachandran, S., Prakash, P., Mohtar, N., Kumar, K. S., & Parumasivam, T. (2023) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2023.2279691 · Cited by 16 · see citing works
The Magnetic, Mechanical, Thermal Properties and Uv Resistance of CoFe2O4/SiO2-Coated Film on Wood
Gan, W., Gao, L., Liu, Y., Zhan, X., & Li, J. (2015) · Journal of Wood Chemistry and Technology · doi:10.1080/02773813.2015.1074247 · Cited by 15 · see citing works
Solid Lipid Nanoparticles in Tuberculosis
Rana, D., Salave, S., Patel, R. P., Khunt, D., Misra, M., Prajapati, B. G., Patel, G. K., & Patel, J. K. (2023) · Springer eBooks · doi:10.1007/978-3-031-14100-3_6 · Cited by 14 · see citing works
Laghari, M., Darwis, Y., Memon, A. H., Khan, A. A., Abdulbaqi, I. M., & Assi, R. A. (2016) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v15i1.28 · Cited by 14 · see citing works
Co-encapsulation of Rifampicin and Isoniazid in Crude Soybean Lecithin Liposomes
Nkanga, C. I., Siwe‐Noundou, X., Walker, R. B., & Krause, R. W. M. (2019) · South African Journal of Chemistry · doi:10.17159/0379-4350/2019/v72a11 · Cited by 13 · see citing works
El‐Azazy, M., El‐Shafie, A. S., Al-Mulla, R., Hassan, S. S., & Nimir, H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15802 · Cited by 12 · see citing works
Ferreira, Q. S., da Silva, S. W., Santos, C. M. B., Ribeiro, G., Guilherme, L. R., & Morais, P. C. (2015) · Journal of Raman Spectroscopy · doi:10.1002/jrs.4718 · Cited by 11 · see citing works
Yadav, C., & Roy, S. (2014) · Journal of Computational Electronics · doi:10.1007/s10825-014-0633-5 · Cited by 11 · see citing works
Mahoney, S., Najera, M., Bai, Q., Burton, E. A., & Veser, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152010 · Cited by 10 · see citing works
Nano-engineered solutions for extensively drug-resistant tuberculosis (XDR-TB): A novel nanomedicine
Singh, D., Krishna, V. S., Kumari, N., Banerjee, A., & Kapoor, P. (2024) · Nano-Structures & Nano-Objects · doi:10.1016/j.nanoso.2024.101390 · Cited by 8 · see citing works
Solid Lipid Based Nano-particulate Formulations in Drug Targeting
Mohanta, B. C., Dinda, S. C., Palei, N. N., & Deb, J. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88268 · Cited by 8 · see citing works
Nanotechnology as a potential tool against drug- and multidrug-resistant tuberculosis
Pérez-Martínez, D. E., & Zenteno‐Cuevas, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819811-7.00003-5 · Cited by 8 · see citing works
Meta-Analysis of Drug Delivery Approaches for Treating Intracellular Infections
Shin, S., Kwon, S., & Yeo, Y. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03188-z · Cited by 8 · see citing works
Nanostructured lipid carrier-based drug delivery systems for tuberculosis treatment
Carneiro, S. P., & dos Santos, O. D. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819811-7.00012-6 · Cited by 7 · see citing works
Surface-modified CuO nanoparticles for photocatalysis and highly efficient energy storage devices
Pandith, A., Jayaprakash, G. K., & ALOthman, Z. A. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-25131-4 · Cited by 7 · see citing works
Suciati, T. A., Rachmawati, P., Soraya, E., Mahardhika, A. B., Satrialdi, Hartarti, R., & Anggadiredja, K. (2018) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2018.81201 · Cited by 7 · see citing works
Applications of Nanotechnology in Phytoremediation
Sharma, A., Mittal, V., Grover, R., Sharma, D., Gupta, V., & Kumar, K. (2024) · Springer eBooks · doi:10.1007/978-3-031-60761-5_14 · Cited by 6 · see citing works
Chokshi, N. V., Vinchhi, P., Chauhan, S., Bora, V. R., Patel, B. M., & Patel, M. M. (2025) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2025.2492136 · Cited by 6 · see citing works
Approaches for designing and delivering solid lipid nanoparticles of distinct antitubercular drugs
Vasam, M., & Goulikar, R. K. (2022) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2022.2144791 · Cited by 5 · see citing works
Lipid nanoparticles as carriers for delivery of anti-inflammatory drugs
Kovačević, A. B., Silva, S. M. C., & Doktorovová, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40016-9.00005-1 · Cited by 5 · see citing works
Makled, S., Nafee, N. A., Okasha, H. A. S., & Boraie, N. A. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106202 · Cited by 4 · see citing works
Precision nanomedicine against pulmonary tuberculosis: the role of lipid-based drug delivery systems
He, N., Dong, K., Lee, W., & Bach, H. (2026) · Nanomedicine · doi:10.1080/17435889.2026.2624741 · Cited by 4 · see citing works
Synthesis and application of streptavidin functionalized organosilica microparticles
Hou, C., Zhang, L., Wang, Y., & Wang, Z. (2014) · Journal of Applied Polymer Science · doi:10.1002/app.41560 · Cited by 4 · see citing works
Rai, P. Y., Sansare, V. A., Warrier, D. U., & Shinde, U. A. (2022) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2022.03.007 · Cited by 4 · see citing works
Host-directed strategies using lipid nanoparticles to reduce mycobacteria survival
Pereira, L. P., Diogo, J., Mateus, R., Pimentel, M., & Videira, M. (2015) · Journal of Nanoparticle Research · doi:10.1007/s11051-015-2892-x · Cited by 4 · see citing works
Mottaqi, M., Langarizadeh, M. A., Molaali, N., Rezaei, M., Ameri, A., & Forootanfar, H. (2024) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-024-00787-6 · Cited by 3 · see citing works
Nanomedicines in Tuberculosis: Diagnosis, Therapy and Nanodrug Delivery
Dakkah, A. N., Bataineh, Y. A., Al-Jaidi, B. A., Bayan, M. F., & Nimer, N. A. (2020) · Engineering materials · doi:10.1007/978-3-030-36260-7_13 · Cited by 3 · see citing works
Chokshi, N. V., Bora, V. R., Rawal, S. U., Vinchhi, P., Gajjar, S., Patel, B. M., & Patel, M. M. (2024) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2024.2348511 · Cited by 3 · see citing works
Nanopartículas como transportadores de fármacos: una herramienta prometedora contra la tuberculosis
Luna‐Herrera, J., Pérez-Martínez, D. E., Barradas-Hernández, V. M., & Zenteno‐Cuevas, R. (2021) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2021.381.6156 · Cited by 3 · see citing works
Monitoring of an Antituberculosis Drug Degradation under UV Radiation
Kais, H., Mezenner, N. Y., Bensaadi, Z., & Hamadi, A. (2022) · Russian Journal of Physical Chemistry A · doi:10.1134/s0036024422100107 · Cited by 2 · see citing works
Evaluation of Lung Toxicity of Biodegradable Nanoparticles
Grabowski, N., Hillaireau, H., Vergnaud, J., & Fattal, E. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-11355-5_22 · Cited by 2 · see citing works
Macrophage-Targeted Chemotherapy for Tuberculosis
Shrivastava, P., Gautam, L., Vyas, S., & Vyas, S. P. (2022) · Springer eBooks · doi:10.1007/978-3-030-84164-5_17 · Cited by 2 · see citing works
Pharmacoengineering of Lipid Nanoarchitectonics in Modulating Particle Uptake by Lung Macrophages
Thalla, M., & Banerjee, S. (2021) · Wiley eBooks · doi:10.1002/9783527832095.ch12 · Cited by 2 · see citing works
Puvvada, N., Chandu, B., & Panigrahi, P. K. (2025) · Wiley eBooks · doi:10.1002/9781394200559.ch11 · Cited by 2 · see citing works
Chokshi, N. V., Naik, J., Bora, V. R., Patel, B. M., & Patel, M. M. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01018 · Cited by 1 · see citing works
Perspective on Solid Lipid Nanoparticles as Drug Delivery System for Infectious Diseases
Ayare, P., Bakre, A., & Hirlekar, R. S. (2024) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.1293 · Cited by 1 · see citing works
Nanotherapeutics in tuberculosis: Pulmonary and extrapulmonary applications
Bisht, S., Jaiswal, V., & Singh, M. F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-28836-4.00011-1 · Cited by 1 · see citing works
Nanomedicines for the treatment of tuberculosis
Donnellan, S. (2016)
- Authors
- Chuan, J., Li, Y., Yang, L., Sun, X., Zhang, Q., Gong, T., & Zhang, Z.
- Affiliations
- Sichuan University (CN)
- Tianjin Institute of Pharmaceutical Research (China) (CN)
- Peking University (CN)
- Corresponding author
- Gong, Tao
- Zhang, Zhirong
- Venue
- Journal of Nanoparticle Research
- Published
- 2013-04-11
- Volume
- 15
- Issue
- 5
- ISSN
- 1388-0764 (ISSN-L)
- 1572-896X
- OpenAlex
- W2016812928
- Cited by
- 107
- References
- 37
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 6 · 2023: 7 · 2022: 9 · 2021: 10 · 2020: 9 · 2019: 11 · 2018: 8 · 2017: 7 · 2016: 11 · 2015: 10 · 2014: 11 · 2013: 1
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Nanoparticle Research (publishedVersion)
- Funders
- International Society of Travel Medicine
- National Key Research and Development Program of China
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- rifampicin, solid lipid nanoparticles, alveolar macrophages, tuberculosis, targeted drug delivery, alveolar type II cells, nanoparticle uptake, pulmonary administration, lipid film hydration, cytotoxicity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review